To investigate the potential targets of FTO in t(8;21) AML cells, we conducted m6A-seq and RNA-seq assays using wild-type FTO-overexpressing and control Kasumi-1 cells (Fig. 5A). Here, FTO is linked to acute myeloid leukemia.